| Q55386077 | Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis. |
| Q41806880 | An unusual association between focal segmental sclerosis and lupus nephritis: a distinct concept from lupus podocytopathy? |
| Q98292928 | Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis |
| Q30235177 | Calcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the Literature |
| Q87393373 | Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults |
| Q37241092 | Clinicopathological correlation and treatment response of primary focal segmental glomerulosclerosis in adults and adolescents |
| Q46291457 | Complete remission of nephrotic syndrome in an infant with focal segmental glomerulosclerosis: is it renin-angiotensin blockade? |
| Q53365410 | Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. |
| Q84978295 | Evidence-based practice guideline for the treatment of CKD |
| Q46188694 | Focal and segmental glomerulosclerosis in children: a longitudinal assessment. |
| Q46439515 | Focal segmental glomerulosclerosis complicating solitary kidney |
| Q35574612 | Focal segmental glomerulosclerosis--epidemiology aspects in children and adults |
| Q24242266 | Immunosuppressive treatment for focal segmental glomerulosclerosis in adults |
| Q38982416 | Minimal change disease and idiopathic FSGS: manifestations of the same disease. |
| Q35110854 | Permeability factors in focal segmental glomerulosclerosis |
| Q33762739 | Ponticelli regimen in idiopathic nephrotic syndrome |
| Q36631784 | Primary focal segmental glomerular sclerosis in children: clinical course and prognosis |
| Q34455143 | Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS |
| Q44752973 | Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome |
| Q36098017 | The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome |
| Q36612823 | The expression of cytoskeletal proteins in kidney specimens of children with primary focal segmental glomerulosclerosis |
| Q37359035 | Treatment of idiopathic FSGS with adrenocorticotropic hormone gel. |
| Q57049336 | Treatment of steroid-resistant nephrotic syndrome in the genomic era |
| Q36686985 | Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS |
| Q33410001 | Women, kidney disease, and pregnancy |
| Q79181938 | [Treatment of glomerulonephritis] |